WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound ...

(Logo: http://www.newscom.com/cgi-bin/prnh/20091117/DA12265LOGO) The program was sponsored in part by a $2.7 million federal educational grant received through the ...

Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine ...

Through its Centers of Excellence program, the MDS Foundation helps patients get appointments with leading experts from around the world. For patients with cancer there is no time to waste. The MDS ...